ADAMA(SZ:000553)2025-11-10 08:00Financial Performance - Q3 2025 - Sales increased by 2.4% to $853 million compared to Q3 2024[12, 14] - Gross profit rose by 18% to $242 million, with gross margin improving to 28.3% from 24.6%[12, 14] - EBITDA surged by 59% to $97 million, with EBITDA margin increasing to 11.3% from 7.3%[12, 14] - Net loss improved by 69% from -$73 million to -$23 million[12] Financial Performance - 9M 2025 - Sales remained stable at $2,698 million, a decrease of 0.8% compared to 9M 2024[15, 17] - Gross profit increased by 11% to $788 million, with gross margin improving to 29.2% from 26.1%[15, 17] - EBITDA increased by 29% to $341 million, with EBITDA margin improving to 12.6% from 9.7%[15, 17] - Net loss significantly improved from -$142 million to approximately $0 million[15, 17] Regional Performance - 9M 2025 - North America experienced a sales growth of 16% at CER[19] - APAC experienced a sales decline of 14% at CER[19]